Over 300 Minnesota Auctions End Tomorrow 11/30 - Bid Now
Over 100 Total Lots Up For Auction at One Location - CA 12/02
Visit DOTmed at RSNA in Chicago. Booth 6801

Butterfly Network introduces Butterfly Blueprint and world's first FDA-cleared AI guidance and interpretation software

Press releases may be edited for formatting or style | February 28, 2022 Ultrasound
GUILFORD, Conn. February 28, 2022 - Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today introduced Butterfly Blueprint™, a system-wide platform designed to support the scaled deployment of ultrasound across hospitals and health systems to empower more-informed clinical decisions from the bedside and encounter-based workflow.

Leveraging Butterfly's unique combination of a whole-body handheld ultrasound device, software, and services, Blueprint brings hospitals and health systems a complete ultrasound solution. This system-wide offering promotes improved patient care via accessible imaging across multiple disciplines and care settings. By integrating into health systems' clinical and administrative systems and workflows, Blueprint delivers a clinical assessment tool at scale.

"Ultrasound provides valuable information. The ability to enable the practical application of ultrasound into the clinical workflow to inform clinical decision making is powerful," said Dr. Todd Fruchterman, Butterfly Network's President and Chief Executive Officer. "Butterfly Blueprint empowers an evolved point-of-care toolkit for hospitals and health systems – one that transcends beyond touch, listening, and surface visuals, and beyond habit-based imaging and lab orders. With Butterfly, clinicians across all disciplines now have a strategic tool that we believe allows them to see and know sooner, helping them drive better care decisions, efficiency, and outcomes."

Butterfly Blueprint is complemented with a rich set of optional software and services including Caption Health's AI-guided software. Caption AI™ empowers healthcare professionals without sonography expertise to capture and interpret cardiac ultrasound images for earlier disease detection and better patient management. The Centers for Medicare and Medicaid Services (CMS) has approved new technology add-on payments (NTAP) for Caption Guidance™– a designation awarded to new medical technologies and services that are expected to substantially improve the diagnosis or treatment of Medicare beneficiaries.

"Deployment on the Blueprint platform is helping us fulfill our mission to put enhanced diagnostic capabilities in more hands and increase access for patients," said Steve Cashman, President and CEO of Caption Health. "By integrating Caption AI with Butterfly iQ+, we're expanding diagnostic toolkits for hospitals, health systems, and wherever a patient needs care. The insights provided by a high-quality ultrasound exam are critical for better care and earlier disease detection. Butterfly and Caption are making that vision not just a possibility, but a reality."

You Must Be Logged In To Post A Comment